No Cross-Reactivity Between Sulfonamide Antibiotics and Glipizide
Glipizide can be safely used in patients with a documented allergy to sulfamethoxazole-trimethoprim, as there is no clinically significant cross-reactivity between sulfonamide antibiotics and sulfonylureas like glipizide. 1
Key Evidence
The 2022 Drug Allergy Practice Parameter from the Journal of Allergy and Clinical Immunology explicitly lists sulfonylureas (including glimepiride, glyburide, and gliclazide) in Table XIV as drugs with "no or weak evidence of cross-reactivity" in patients with a history of sulfonamide antimicrobial adverse reactions 1. While glipizide is not specifically named in the table, it belongs to the same sulfonylurea class and shares the same structural characteristics.
Why There's No Cross-Reactivity
The structural basis for this lack of cross-reactivity is clear:
- Sulfonamide antimicrobials (like sulfamethoxazole) contain an aromatic amine group at the N4 position, which is responsible for hypersensitivity reactions 1
- Sulfonylureas (like glipizide) lack this aromatic amine group at the N4 position
- The sulfonamide moiety alone is insufficient to cause cross-reactivity
Because of this structural difference, there is minimal concern for cross-reactivity between sulfonamide antibiotics and nonantimicrobial sulfonamides 1.
Supporting Research Evidence
Multiple studies confirm this lack of cross-reactivity:
- A 2004 study of 28 patients with fixed drug eruption from sulfonamide antibiotics found that all patients (n=28) tolerated glipizide with no reactions 2
- A 2013 systematic review found no convincing evidence of broad cross-reactivity between antibacterial and nonantibacterial sulfonamide agents 3
- A 2023 comprehensive review confirmed that cross-reactivity between sulfonamide antibiotics and non-antibiotic sulfonamides is not clearly demonstrated 4
Important Caveat: Drug-Drug Interaction
While there is no allergic cross-reactivity, be aware that sulfamethoxazole-trimethoprim can potentiate the hypoglycemic effects of glipizide through a pharmacokinetic interaction 5, 6. The FDA label explicitly warns that "like other sulfonamide-containing drugs, sulfamethoxazole and trimethoprim potentiates the effect of oral hypoglycemics" 6. This interaction occurs through:
- Inhibition of CYP2C9 (glipizide metabolism pathway)
- Inhibition of OCT2 transporter
- Potential protein binding displacement
This is a pharmacologic interaction, not an allergic cross-reaction. One case report documented symptomatic hypoglycemia when TMP-SMX was added to glipizide therapy 7, and a 2022 study found high concurrent use of these medications with resultant hypoglycemic events 8.
Clinical Bottom Line
- Prescribe glipizide without hesitation in patients allergic to sulfamethoxazole-trimethoprim
- No allergy testing or desensitization is needed
- If both medications must be used together (for different indications), monitor blood glucose closely for hypoglycemia, but this is a separate pharmacologic concern unrelated to allergy